Both in Pharmaceuticals
Yarrow Bioscience vs Minerva Neurosciences
Over the past year YARW returned −44.8% and NERV returned −38.1%; their daily moves had a correlation of -0.21.
YARW −44.8% NERV −38.1%Growth of $1, one year, split-adjusted
| Metric | YARW | NERV |
|---|---|---|
| Price | $14.91 | $2.57 |
| Market cap | $125.8M | $122.7M |
| Today | −18.84% | +9.36% |
| 1 month | −20.4% | −25.1% |
| 6 months | — | −58.7% |
| Year to date | — | −36.1% |
| 1 year | — | −32.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 79.8% |
| Short % of float | 2.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).